Targeted delivery of polo-like kinase 1 siRNA nanoparticles using an EGFR-PEG bispecific antibody inhibits proliferation of high-risk neuroblastoma.
- Resource Type
- Article
- Source
- In
Journal of Controlled Release March 2024 367:806-820 - Subject
- Language
- ISSN
- 0168-3659